Neuropharmacology

Published by: Pergamon-Elsevier Science Ltd  

People

  1. Sinha
    Sinha
  2. Ventura
    Ventura

Groups

  1. Sloan Kettering Institute Faculty (11)
  2. Molecular Pharmacology and Chemistry Program Faculty (10)
  3. Sloan Kettering Institute Postdocs (5)
  4. Anesthesiology Service (1)
  5. Anesthesiology and Critical Care Medicine (1)
  6. Cancer Biology and Genetics Program Faculty (1)
  7. Center for Molecular Imaging and Biotechnology (1)
  8. GSK Faculty (1)
Search Within
Formats
  1. Journal Article (14)
  2. Editorial (1)
Groups
  1. Sloan Kettering Institute Faculty (11)
  2. Molecular Pharmacology and Chemistry Program Faculty (10)
  3. Sloan Kettering Institute Postdocs (5)
  4. Anesthesiology Service (1)
  5. Anesthesiology and Critical Care Medicine (1)
  6. Cancer Biology and Genetics Program Faculty (1)

More Groups

People
  1. Gavril Pasternak (10)
  2. Rajendra Uprety (3)
  3. Ruth Reinsel (2)
  4. Susruta Majumdar (2)
  5. Valerie Le Rouzic (2)
  6. Vladimir Feschenko (2)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2016 (1)

More Years

Publishers
  1. Pergamon-Elsevier Science Ltd (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl
    Journal Article

    Xie, B.; Le Rouzic, V. P.; Goldberg, A.; Tsai, M. H. M.; Chen, L.; Zhang, T.; Sinha, A.; Pan, Y. X.; Baumann, M. H.; Shi, L.
    Neuropharmacology (2023)

    Fulltext@MSK | Save
  • The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain
    Journal Article

    Atigari, D. V.; Paton, K. F.; Uprety, R.; Váradi, A.; Alder, A. F.; Scouller, B.; Miller, J. H.; Majumdar, S.; Kivell, B. M.
    Neuropharmacology (2021)

    Fulltext@MSK | Save
  • Confronting the opioid crisis with basic research in neuropharmacology
    Editorial

    Baumann, M. H.; Pasternak, G. W.; Negus, S. S.
    Neuropharmacology (2020)

    Fulltext@MSK | Save
  • MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats
    Journal Article

    Atigari, D. V.; Uprety, R.; Pasternak, G. W.; Majumdar, S.; Kivell, B. M.
    Neuropharmacology (2019)

    Fulltext@MSK | Save
  • Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace
    Journal Article

    Baumann, M. H.; Majumdar, S.; Le Rouzic, V.; Hunkele, A.; Uprety, R.; Huang, X. P.; Xu, J.; Roth, B. L.; Pan, Y. X.; Pasternak, G. W.
    Neuropharmacology (2018)

    Fulltext@MSK | Save
  • Effects of lack of microRNA-34 on the neural circuitry underlying the stress response and anxiety
    Journal Article

    Andolina, D.; Di Segni, M.; Bisicchia, E.; D'Alessandro, F.; Cestari, V.; Ventura, A.; Concepcion, C.; Puglisi-Allegra, S.; Ventura, R.
    Neuropharmacology (2016)

    Fulltext@MSK | Save
  • Opioids and their receptors: Are we there yet?
    Journal Article

    Pasternak, G. W.
    Neuropharmacology (2014)

    Fulltext@MSK | Save
  • Multiple opiate receptors: Déjà vu all over again
    Journal Article

    Pasternak, G. W.
    Neuropharmacology (2004)

    Fulltext@MSK | Save
  • Propofol-induced alpha rhythm
    Journal Article

    Feschenko, V. A.; Veselis, R. A.; Reinsel, R. A.
    Neuropharmacology (2004)

    Fulltext@MSK | Save
  • Comparison of the EEG effects of midazolam, thiopental, and propofol: The role of underlying oscillatory systems
    Journal Article

    Feshchenko, V. A.; Veselis, R. A.; Reinsel, R. A.
    Neuropharmacology (1997)

    Fulltext@MSK | Save

    • Neuropharmacology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuropharmacology 0028-3908 Elsevier Science, Inc.
    Neuropharmacology 00283908 Unknown
    Neuropharmacology 00283908 Elsevier Ltd
    Neuropharmacology 0028-3908 Pergamon-Elsevier Science Ltd
    Neuropharmacology 0028-3908 2020
    Neuropharmacology 0028-3908 Elsevier Ltd
    Neuropharmacology 0028-3908 Unknown
    Neuropharmacology 00283908 1992
    Neuropharmacology 0028-3908 Pergamon-Elsevier Science Ltd
    Neuropharmacology 00283908 Elsevier Inc.
    Neuropharmacology 0028-3908 Pergamon-Elsevier Science Ltd
    Neuropharmacology 0028-3908 Elsevier Inc.
    Neuropharmacology 00283908 2020
    Neuropharmacology 00283908 2017
    Neuropharmacology 00283908 1994
    Neuropharmacology 00283908 2023
    Neuropharmacology 00283908 Elsevier Inc.
    Neuropharmacology 0028-3908 Elsevier Ltd
    Neuropharmacology 0028-3908 Pergamon-Elsevier Science Ltd
    Neuropsychobiology 0302-282X Karger Switzerland
    Neuropsychobiology 0302282X S. Karger AG
    Neuropsychobiology 0302-282X Karger
    Neuropsychobiology 0302282X Unknown
    Neuropsychobiology 0302-282X Karger
    Neuropsychobiology 0302-282X Unknown